Definitive Contract HHSF223201510057C
Award Date
7/31/15
Potential Completion Date
7/15/20
Potential Value
$21M
Federal Agency
Food and Drug Administration
Ultimate Awardee
Not listed
PSC Category
Q515 - Medical- Pathology
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
Jefferson, AR 72079, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>This is a definitive contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Toxicologic Pathology Associates Inc., a small business, for on-site pathology services. The contract has a ceiling value of $23,962,468.37 and a period of performance through July 18, 2025. It is a labor hours contract, which indicates the contractor will be paid based on the number of labor hours expended. The contract was set aside for small businesses.</p>
This firm-fixed-price delivery order was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Experimental Pathology Laboratories, Inc. (EPL), a for-profit subchapter S corporation. The $11,218.32 contract is for pathology support services, and does not have a set-aside designation. EPL is a contract research organization that specializes in toxicology pathology services and has a history of providing advanced scientific and laboratory services to various government...
This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Experimental Pathology Laboratories, Inc. (EPL), a for-profit, employee-owned contract research organization. The contract, valued at $128,835.41, is for pathology support services and does not have a set-aside designation. EPL, which is registered in the System for Award Management (SAM) through January 2026, has extensive experience providing specialized...
This federal contract award was issued by the Food and Drug Administration (FDA), a civilian agency, to Experimental Pathology Laboratories, Inc. (EPL), a for-profit, employee-owned contract research organization headquartered in Sterling, Virginia. The $461,566.87 firm fixed-price delivery order is for pathology support services and does not have a set-aside designation. EPL, which is registered in the System for Award Management (SAM) through January 2026, has established itself as a...
This federal contract award is for a Toxicologist II position with the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services. The contract was awarded to Goldbelt C6, LLC, an Alaska Native Corporation-owned small disadvantaged business, on August 29, 2022, with a ceiling value of $164,228.38 and a completion date of September 5, 2023. The contract is a Delivery Order with a Labor Hours pricing type. Goldbelt C6 is a subsidiary of...
The Department of Health and Human Services Food and Drug Administration (FDA) awarded a $21,248,120.84 definitive contract to Priority One Services, Inc., a minority-owned and self-certified small disadvantaged business, for on-site multi-center animal husbandry support services to the FDA's Animal Care and Use Programs (ACUP). This is a labor-hour contract to provide administrative support, animal care and oversight, and veterinary technical services for the FDA's animal research programs. The...
The Food and Drug Administration (FDA) awarded a $91,630 firm-fixed-price purchase order contract to Discovery Life Sciences, LLC, a small disadvantaged business, for the delivery of 110 vials of primary cryopreserved human hepatocytes. This requirement supports the FDA's National Center of Toxicological Research (NCTR) Division of Biochemical Toxicology's research into drug toxicity and metabolic enzymes. The contract has a period of performance through August 19, 2024 and was awarded under a...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm fixed price purchase order to The Society of Toxicology (SOT), a non-profit organization, for the "THE SOCIETY OF TOXICOLOGY/FDA COLLOQUIA ON EMERGING TOXICOLOGICAL SCIENCE CHALLENGES IN FOOD AND INGREDIENT SAFETY" with a potential value of $125,629.00. The contract, which does not have a set-aside designation, is for the provision of scientific engagement, education, and workforce...
The U.S. Food and Drug Administration (FDA) awarded a $20,963,282.16 Definitive Contract to The Bionetics Corp, a for-profit engineering firm headquartered in Virginia, to provide on-site animal care and technical procedures services in support of the FDA's National Center for Toxicological Research (NCTR) animal research program. This contract is a 100% small business set-aside with a one-year base period and four one-year option periods. The services required include animal care, facility...
This is a federal contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Experimental Pathology Laboratories, Inc. (EPL), a for-profit Subchapter S corporation. The contract is for "PATHOLOGY PEER REVIEW AND PATHOLOGY SUPPORT FOR THE DNTP AND DIR AT NIEHS" with a ceiling value of $44,901,907.54 and a period of performance through July 27, 2025. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type. It was...